| Key Financial Ratios of Sun Pharma Advanced Research Company (in Rs. Cr.) |
Mar 20 |
Mar 19 |
Mar 18 |
Mar 17 |
Mar 16 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
-11.92 |
-5.69 |
-7.94 |
-4.87 |
-2.96 |
|
| Diluted EPS (Rs.) |
-11.92 |
-5.69 |
-7.94 |
-4.87 |
-2.96 |
|
| Cash EPS (Rs.) |
-11.56 |
-5.49 |
-7.52 |
-4.49 |
-2.64 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
-0.71 |
11.80 |
7.36 |
6.41 |
1.26 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
-0.71 |
11.80 |
7.36 |
6.41 |
1.26 |
|
| Dividend / Share(Rs.) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Revenue from Operations/Share (Rs.) |
2.93 |
7.29 |
3.12 |
7.33 |
6.81 |
|
| PBDIT/Share (Rs.) |
-11.46 |
-5.49 |
-9.47 |
-4.41 |
-2.55 |
|
| PBIT/Share (Rs.) |
-11.82 |
-5.79 |
-9.80 |
-4.75 |
-2.87 |
|
| PBT/Share (Rs.) |
-11.92 |
-5.80 |
-7.85 |
-4.82 |
-2.96 |
|
| Net Profit/Share (Rs.) |
-11.92 |
-5.80 |
-7.85 |
-4.82 |
-2.96 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
-390.87 |
-75.34 |
-303.69 |
-60.20 |
-37.36 |
|
| PBIT Margin (%) |
-403.21 |
-79.47 |
-314.15 |
-64.75 |
-42.05 |
|
| PBT Margin (%) |
-406.69 |
-79.52 |
-251.72 |
-65.75 |
-43.39 |
|
| Net Profit Margin (%) |
-406.69 |
-79.52 |
-251.72 |
-65.75 |
-43.39 |
|
| Return on Networth / Equity (%) |
0.00 |
-49.09 |
-106.64 |
-75.26 |
-234.06 |
|
| Return on Capital Employed (%) |
-832.42 |
-47.89 |
-102.23 |
-72.35 |
-185.04 |
|
| Return on Assets (%) |
-114.61 |
-36.49 |
-63.79 |
-43.67 |
-43.02 |
|
| Total Debt/Equity (X) |
-3.64 |
0.00 |
0.01 |
0.02 |
1.85 |
|
| Asset Turnover Ratio (%) |
28.18 |
45.89 |
25.34 |
66.42 |
99.15 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
0.29 |
2.71 |
1.51 |
1.47 |
0.53 |
|
| Quick Ratio (X) |
0.29 |
2.71 |
1.51 |
1.47 |
0.53 |
|
| Inventory Turnover Ratio (X) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Dividend Payout Ratio (NP) (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Dividend Payout Ratio (CP) (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Earnings Retention Ratio (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Cash Earnings Retention Ratio (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
2,596.18 |
4,818.56 |
9,494.88 |
7,751.74 |
6,858.14 |
|
| EV/Net Operating Revenue (X) |
33.80 |
26.35 |
121.33 |
42.82 |
42.52 |
|
| EV/EBITDA (X) |
-8.65 |
-34.97 |
-39.95 |
-71.13 |
-113.82 |
|
| MarketCap/Net Operating Revenue (X) |
32.92 |
26.35 |
121.32 |
43.20 |
42.26 |
|
| Retention Ratios (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Price/BV (X) |
-135.69 |
16.26 |
51.40 |
49.44 |
227.93 |
|
| Price/Net Operating Revenue |
32.92 |
26.35 |
121.32 |
43.20 |
42.26 |
|
| Earnings Yield |
-0.12 |
-0.03 |
-0.02 |
-0.02 |
-0.01 |
|
Source : Dion Global Solutions Limited
